General Announcement::PRESS RELEASE:BIOLIDICS TO BROADEN PRESENCE IN CHINA CANCER DIAGNOSTICS MARKET WITH NEW PARTNERSHIP
Issuer & Securities
Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
25-Jun-2019 17:35:33
Status
New
Announcement Sub Title
PRESS RELEASE:BIOLIDICS TO BROADEN PRESENCE IN CHINA CANCER DIAGNOSTICS MARKET WITH NEW PARTNERSHIP
Announcement Reference
SG190625OTHRJ2D0
Submitted By (Co./ Ind. Name)
Lew Kwang Ping
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to attachment.
Attachments
Biolidics_TOPGene partnership_press release.pdf
Total size =846K
Related Announcements
Related Announcements